TCL Archive Coulter And Venture Capital Firm Form Company To Develop B1 Antibody For NHL April 28, 1995
TCL Archive In Brief: NCI Gets $867 Million From Conferees; Grants To Be Funded At 41-42% Including Some Holdovers July 29, 1977
TCL Archive The Cancer Letter Obtains “Confidential” Documents From Duke IRB Investigation May 14, 2010
TCL Archive In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List December 2, 1983